Sapan Ghai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSylvania Platinum Regulatory News (SLP)

Share Price Information for Sylvania Platinum (SLP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 72.00
Bid: 71.00
Ask: 73.00
Change: 0.20 (0.28%)
Spread: 2.00 (2.817%)
Open: 71.00
High: 72.50
Low: 71.00
Prev. Close: 71.80
SLP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sylvania and Aquarius Agreement re Everest North

3 Jun 2011 07:00

RNS Number : 8124H
Sylvania Platinum Limited
03 June 2011
 



Sylvania Platinum Limited

("Sylvania Platinum", "Sylvania" or the "Company")

(ASX: SLP, AIM: SLP)

 

Sylvania and Aquarius SA Agreement to Assess Everest North UG2

Platinum Deposit, South Africa

 

Highlights

·; Agreement with Aquarius Platinum (South Africa) (Pty) Limited ("AQPSA") relating to PGM bearing ore at Vygenhoek Prospecting Area ("Everest North")

·; Feasibility Committee formed to:

- Examine and update existing feasibility study for processing of PGM bearing ore produced at Everest North

- Apply for mining Licence

·; Joint Venture ("JV") to subsequently be formed

- Ore to be processed through AQPSA's Everest South Metallurgical Plant

- AQPSA will make available a minimum of 27 000 tons per month of processing capacity

- PGM concentrate expected to be sold to Impala Refining Services

- Mining and processing costs to be carried by the Joint Venture

Sylvania Platinum, the low cost Platinum Group Metal producer, today announces that it has entered into an agreement with Aquarius Platinum (South Africa) (Pty) Limited ("AQPSA"), a wholly owned subsidiary of Aquarius Platinum Limited, the world's fourth largest primary platinum producer, to examine the feasibility of extracting and processing ore from the Everest North deposit.

Following a six month exclusivity period, calculated from 1 June 2011, a Feasibility Committee (the "Committee") willreview and update the existing feasibility study. The Committee will specifically look at demonstrating the viability of mining for PGMs at Everest North and thereafter treating and concentrating the PGMs at the Everest South Metallurgical Plant to produce saleable PGM concentrate. The Committee shall also compile an application for a Mining Right for Everest North.

Sylvania shall bear all costs related to independent third party experts employed to assist with achieving the objectives of the Committee.

AQPSA and Sylvania will, in the event that the Committee determines that mining for PGMs at Everest North is viable, agree on the conclusion of a Joint Venture Agreement to form an unincorporated joint venture, in which AQPSA and Sylvania will each hold an undivided 50% share ("Joint Venture"), to implement the project. Conclusion of the Joint Venture will be conditional on obtaining approvals from the Boards of Sylvania and AQPSA and obtaining all relevant regulatory approvals. The Joint Venture will have a management committee with equal representation by the parties, to manage and oversee the implementation of the project.

Sylvania will, on the date of the granting by the Department of Mineral Resources of a New Order Mining Right to AQPSA and AQPSA contributing this right to the Joint Venture, pay AQPSA an amount of R6 million in cash.

The Joint Venture shall appoint AQPSA as contract miner to carry out all mining at Everest North, for and on behalf of the Joint Venture, on terms and conditions to be agreed upon between the parties and recorded in the Feasibility Study, which terms and conditions shall be reduced to writing and recorded in a contract mining agreement to be concluded between the Joint Venture and AQPSA.

It is intended that PGM bearing ore produced by the Joint Venture shall be processed through the Everest South Metallurgical Plant and AQPSA shall be entitled to receive from the Joint Venture the costs of the production of PGM concentrate at the Everest South Metallurgical Plant, which costs will be determined in the Feasibility Study. AQPSA will make available to the Joint Venture, a minimum of 27 000 tons per month of its processing capacity at the Everest South Metallurgical Plant, at the aforementioned cost of processing that tonnage. All PGM concentrate produced from mining by the Joint Venture at Everest North shall be sold by the Joint Venture, in accordance with a Concentrate Off-Take Agreement, still to be concluded.

The costs of the mining by the Joint Venture and the costs of the processing at the Everest South Metallurgical Plant will be carried by the Joint Venture and accordingly, the parties will contribute to those costs and share in the profits of the Joint Venture in accordance with their participation interest in the Joint Venture from time to time, which will initially be 50% each.

Terry McConnachie, the Sylvania CEO, commented "Today's agreement with a world-renowned platinum producer will allow us to successfully exploit significant value from the Vygenhoek Prospecting Area. While we are effectively giving away half of our ore resource the advantage to Sylvania is a vastly reduced capex bill and thus increased IRR and NPV. The area has further resource potential for Platinum Group Metals and we are delighted that by signing this JV we are now in a position to re-examine the feasibility study with our new partners, Aquarius Platinum."

ENDS

 

For further information please contact: 

South AfricaTerence McConnachie (CEO)

 Sylvania Platinum Limited+27 (11) 673 1171

 

 Louis Carroll (FD/Joint Company Secretary)Sylvania Platinum Limited+44 (0) 7969 170 622

 

Australia

Richard Rossiter (Chairman)Sylvania Platinum Limited

+61 (4) 1868 8338

 

 Grant Button (Director/Joint Company Secretary)

Sylvania Platinum Limited+61 (8) 9226 4777

United KingdomAnthony Rowland/ Ben WrightAmbrian Partners Limited+44 (0) 20 7634 4700

 

Laurence Read/Beth Harris

Threadneedle Communications

+44 (0) 20 7653 9855

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGREXLBBFQFXBBD
Date   Source Headline
30th Apr 20247:00 amRNSThird Quarter Report to 31 March 2024
8th Apr 20247:00 amRNSShare Buyback Update
2nd Apr 20247:00 amRNSShare Buyback Update
28th Mar 20247:00 amRNSShare Buyback Update
27th Mar 20247:00 amRNSShare Buyback
26th Mar 20247:00 amRNSShare Buyback
25th Mar 20247:00 amRNSShare Buyback
22nd Mar 20247:00 amRNSShare Buyback
21st Mar 20247:00 amRNSShare Buyback
20th Mar 20249:56 amRNSShare Buyback
19th Mar 20247:00 amRNSShare Buyback Update
18th Mar 20247:00 amRNSShare Buyback Update
15th Mar 20247:00 amRNSShare Buyback Update
14th Mar 20247:00 amRNSShare Buyback Update
11th Mar 20247:00 amRNSShare Buyback Update
8th Mar 20247:00 amRNSShare Buyback Update
7th Mar 20247:00 amRNSShare Buyback Update
6th Mar 20247:00 amRNSShare Buyback Update
5th Mar 20247:00 amRNSShare Buyback Update
4th Mar 20247:00 amRNSShare Buyback
23rd Feb 202412:39 pmRNSDirector/PDMR Shareholding
22nd Feb 20247:00 amRNSUpdated Corporate Presentation Announcement
22nd Feb 20247:00 amRNSInterim Financial Results Announcement
19th Feb 20247:01 amRNSResults of Updated Mineral Resource Estimates
16th Feb 20247:00 amRNSResults of Updated Mineral Resource Estimates
31st Jan 20247:00 amRNSSecond Quarter Report to 31 December 2023
2nd Jan 20247:00 amRNSTotal Voting Rights
27th Nov 20237:00 amRNSResult of AGM
17th Nov 20237:00 amRNSExercise of vested bonus shares
13th Nov 20237:00 amRNSNotice of Transaction by PDMR
9th Nov 20237:00 amRNSAppointment of New Chair
1st Nov 20234:09 pmRNSESG: Supporting Our Strategy Announcement
27th Oct 20237:00 amRNSNotice of AGM
25th Oct 20237:00 amRNSFirst Quarter Report to 30 September 2023
12th Sep 20237:00 amRNSNotice of Transaction by PDMR
7th Sep 20237:07 amRNSPublication of Corporate Investor Presentation
7th Sep 20237:04 amRNSAnnual Financial Report
27th Jul 20234:11 pmRNSFourth Quarter Report to 30 June 2023
27th Jul 20237:00 amRNSFourth Quarter Report to 30 June 2023
14th Jul 202312:35 pmRNSCancellation of Ordinary Shares
3rd Jul 20237:00 amRNSShare Buyback Update
30th Jun 20237:00 amRNSShare Buyback Update
29th Jun 20237:00 amRNSShare Buyback Update
28th Jun 20237:00 amRNSShare Buyback Update
27th Jun 20237:00 amRNSShare Buyback Update
26th Jun 20237:00 amRNSShare Buyback Update
23rd Jun 20237:00 amRNSShare Buyback Update
22nd Jun 20237:00 amRNSShare Buyback Update
21st Jun 20237:00 amRNSShare Buyback Update
20th Jun 20237:00 amRNSShare Buyback Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.